A review of relative dose intensity and survival in patients with metastatic solid tumors.

Havrilesky, Laura J; Reiner, Maureen; Morrow, Phuong Khanh; Watson, Holly; Crawford, Jeffrey

Havrilesky, Laura J; Reiner, Maureen; Morrow, Phuong Khanh; Watson, Holly; Crawford, Jeffrey.

Afiliación

Havrilesky LJ; Division of Gynecology Oncology, Duke University Medical Center, Durham, NC, USA; Duke Cancer Institute, Durham, NC, USA.
Reiner M; Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA.
Morrow PK; Hematology/Oncology, Amgen Inc., Thousand Oaks, CA, USA.
Watson H; Hematology/Oncology, Amgen Inc., Thousand Oaks, CA, USA.
Crawford J; Duke Cancer Institute, Durham, NC, USA; Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. Electronic address: jeffrey.a.crawford@duke.edu.

Crit Rev Oncol Hematol ; 93(3): 203-10, 2015 Mar.

Article en En | MEDLINE | ID: mdl-25459671

Asunto(s)

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Neoplasias/tratamiento farmacológico; Neoplasias/mortalidad; Antineoplásicos/administración & dosificación; Humanos; Metástasis de la Neoplasia; Neoplasias/patología; Pronóstico; Resultado del Tratamiento

Palabras clave

Breast cancer; Lung cancer; Metastatic disease; Outcomes; Ovarian cancer; Relative dose intensity; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google